Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung …
HMT Thomas, DS Hippe, P Forouzannezhad… - Discover Oncology, 2022 - Springer
Background Patients undergoing chemoradiation and immune checkpoint inhibitor (ICI)
therapy for locally advanced non-small cell lung cancer (NSCLC) experience pulmonary …
therapy for locally advanced non-small cell lung cancer (NSCLC) experience pulmonary …
Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation …
HMT Thomas, J Zeng, HJ Lee, Jr… - The British Journal of …, 2019 - academic.oup.com
Objective: The effect of functional lung avoidance planning on radiation dose-dependent
changes in regional lung perfusion is unknown. We characterized dose-perfusion response …
changes in regional lung perfusion is unknown. We characterized dose-perfusion response …
Evaluation of two adaptive radiotherapy workflows and their benefits for stage III non-small cell lung cancer patients using cone-beam computed tomography-based …
LG Hoppen - 2024 - archiv.ub.uni-heidelberg.de
The goal of radiation therapy is to maximize the tumor control probability while minimizing
the normal tissue complication probability. For stage III non-small cell lung cancer patients …
the normal tissue complication probability. For stage III non-small cell lung cancer patients …